Urgent.News

What's breaking now, across hundreds of outlets.

Finance & Markets

Procter & Gamble Has Raised Its Dividend 70 Straight Years. Here's Why I'd Buy Before 2027.

P&G's 70-year dividend streak is the headline, but what the company is changing right now is the real reason I'd buy.

Procter & Gamble (PG) has consistently increased its dividend for an impressive 70 years, and this article argues that the stock is a strong buy ahead of 2027. The company's recent success with its premium diaper, Pampers Amoira, highlights its strategy of targeting families having fewer babies, who are willing to pay more for each child. CFO Andre Schulten believes that P&G's most interesting product this year may actually be Amoira, already on track to reach $100 million in U.S. sales in its first year.

Beyond Pampers Amoira, P&G is focusing on growing its categories rather than simply taking market share. This includes spending more time in shoppers' homes, creating brand content for algorithm-driven social feeds, and partnering with retailers on various displays and AI-powered tools. The company has also acquired Thorne, a well-established supplement brand, further strengthening its product portfolio.

A key part of P&G's strategy is a restructuring program that will cut up to 7,000 non-manufacturing jobs and exit weaker brands and markets over the next two fiscal years. While higher oil prices will bring cost headwinds in the second half of fiscal 2027, the company remains committed to improving results semester by semester and year by year.

Despite a modest price-to-earnings ratio of around 26 and limited pricing power due to past price increases having only a minor effect on sales, P&G's trusted brands, leaner cost structure, and innovative products like Amoira present a compelling case for investors. The article suggests that buying before the financial benefits become apparent is a wiser choice than waiting until they are more obvious, as the company's economic moat and long-term growth potential are likely to reward patient investors.

Rewritten by urgent.news; may contain errors — check the original.

Sources: fool.com · nasdaq.com

Also reported by 1 other outlet

Every outlet that reported this, and when →

Read the original at fool.com →

Report a problem with this story

More in Finance & Markets

More from Sunday 22 November →